Marc M Baum
Overview
Explore the profile of Marc M Baum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gengiah T, Heck C, Lewis L, Mansoor L, Harkoo I, Myeni N, et al.
J Int AIDS Soc
. 2025 Feb;
28(2):e26426.
PMID: 39981604
Introduction: Long-acting HIV pre-exposure prophylaxis promises to improve uptake, adherence and persistence challenges experienced with daily oral tablets. We assessed the acceptability of an annual tenofovir alafenamide (TAF) implant in...
2.
Akhavein N, Baum M, Gunawardana M, Moss J, Calvez S, Remedios-Chan M, et al.
Sci Rep
. 2024 May;
14(1):11573.
PMID: 38773172
GSK2838232 (GSK8232) is a second-generation maturation inhibitor (MI) developed for the treatment of HIV with excellent broad-spectrum virological profiles. The compound has demonstrated promising clinical results as an orally administered...
3.
Rahman M, Bissa M, Silva de Castro I, Hait S, Stamos J, Bhuyan F, et al.
Nat Microbiol
. 2023 May;
8(8):1600.
PMID: 37217721
No abstract available.
4.
Rahman M, Bissa M, Silva de Castro I, Hait S, Stamos J, Bhuyan F, et al.
Nat Microbiol
. 2023 Apr;
8(5):905-918.
PMID: 37024617
The human immunodeficiency virus epidemic continues in sub-Saharan Africa, and particularly affects adolescent girls and women who have limited access to antiretroviral therapy. Here we report that the risk of...
5.
Gallay P, Ramirez C, Baum M
Sci Rep
. 2023 Mar;
13(1):4594.
PMID: 36944714
Adolescent girls and young women in low- to middle-income countries are disproportionately at risk of becoming HIV-1 infected. New non-vaccine biomedical products aimed at overcoming this global health challenge need...
6.
Liu M, Miguel R, Quispe Calla N, Aceves K, Fritts L, Miller C, et al.
Tissue Barriers
. 2023 Mar;
12(1):2186672.
PMID: 36899465
The injectable progestin depot-medroxyprogesterone acetate (DMPA) is a popular contraceptive choice in sub-Saharan Africa although mouse models indicate it weakens genital epithelial integrity and barrier function and increases susceptibility to...
7.
Liu M, Miguel R, Quispe Calla N, Aceves K, Fritts L, Miller C, et al.
bioRxiv
. 2023 Feb;
PMID: 36747683
The injectable progestin depot-medroxyprogesterone acetate (DMPA) is a popular contraceptive choice in sub-Saharan Africa although mouse models indicate it weakens genital epithelial integrity and barrier function and increases susceptibility to...
8.
Gunawardana M, Cortez Jr J, Breslin J, Webster S, Rochman N, Anton P, et al.
Microbiol Spectr
. 2022 Dec;
10(6):e0446922.
PMID: 36453916
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection kinetics in a real-world, clinical setting represent a knowledge gap in understanding the underlying coronavirus disease 2019 (COVID-19) pathogenesis. There are...
9.
Gunawardana M, Remedios-Chan M, Sanchez D, Fanter R, Webster S, Webster P, et al.
Pharm Res
. 2022 Nov;
40(7):1657-1672.
PMID: 36418671
Purpose: Long-acting formulations of the potent antiretroviral prodrug tenofovir alafenamide (TAF) hold potential as biomedical HIV prevention modalities. Here, we present a rigorous comparison of three animal models, C57BL/6 J...
10.
Thomas D, Kiser J, Baum M
Clin Infect Dis
. 2022 Nov;
75(Suppl 4):S517-S524.
PMID: 36410388
There are an estimated 257 million persons living with chronic hepatitis B for whom there are multiple potential applications of long-acting antiviral compounds. Current efforts include both injection and implant...